Northway Biotech is a leading contract development and manufacturing organization (CDMO) specializing in biologics. Established in 2004, it operates FDA- and EMA-compliant facilities in Vilnius (Lithuania), London (UK), and Waltham, Massachusetts (USA). The company provides end-to-end services, including cell line development, process development, formulation, analytical method development, and cGMP manufacturing of drug substances and products. Expanding into gene therapy, Northway launched a Gene Therapy Center in Vilnius under the BIO CITY project, offering viral vector and plasmid manufacturing, cell banking, and quality testing. The company has recently partnered with firms like Micreos Pharmaceuticals and Mallia Therapeutics to support the production of innovative therapies for atopic dermatitis and hair loss. With over 175 projects completed for more than 90 clients globally, Northway Biotech is recognized for its agility, technical depth, and commitment to advancing biopharmaceutical manufacturing